Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 5 studies | 20% ± 4% | |
squamous epithelial cell | 3 studies | 26% ± 11% | |
classical monocyte | 3 studies | 19% ± 3% | |
myeloid cell | 3 studies | 20% ± 3% | |
macrophage | 3 studies | 23% ± 4% |
Insufficient scRNA-seq data for expression of GBA1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 1103.46 | 180 / 180 | 100% | 50.31 | 430 / 430 |
stomach | 100% | 1252.89 | 359 / 359 | 100% | 44.94 | 286 / 286 |
skin | 100% | 2490.62 | 1808 / 1809 | 100% | 132.71 | 472 / 472 |
lung | 100% | 1931.76 | 578 / 578 | 100% | 52.27 | 1153 / 1155 |
esophagus | 100% | 1369.51 | 1441 / 1445 | 100% | 46.14 | 183 / 183 |
pancreas | 99% | 1073.61 | 326 / 328 | 100% | 44.99 | 178 / 178 |
breast | 100% | 1651.64 | 459 / 459 | 99% | 72.84 | 1111 / 1118 |
thymus | 100% | 2131.45 | 653 / 653 | 99% | 49.70 | 599 / 605 |
intestine | 100% | 1553.96 | 965 / 966 | 99% | 38.93 | 521 / 527 |
prostate | 100% | 1267.48 | 244 / 245 | 99% | 43.27 | 497 / 502 |
kidney | 100% | 1705.90 | 89 / 89 | 99% | 58.40 | 888 / 901 |
uterus | 100% | 1459.76 | 170 / 170 | 98% | 42.30 | 452 / 459 |
bladder | 100% | 1471.14 | 21 / 21 | 98% | 46.85 | 495 / 504 |
brain | 98% | 1164.31 | 2576 / 2642 | 100% | 47.04 | 703 / 705 |
adrenal gland | 100% | 2763.91 | 258 / 258 | 96% | 49.95 | 220 / 230 |
liver | 93% | 792.44 | 211 / 226 | 100% | 65.91 | 404 / 406 |
adipose | 100% | 1560.64 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 129.34 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 38.61 | 29 / 29 |
spleen | 100% | 1953.55 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 38.74 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 19.55 | 1 / 1 |
peripheral blood | 100% | 3477.50 | 928 / 929 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1739.70 | 1333 / 1335 | 0% | 0 | 0 / 0 |
heart | 90% | 779.71 | 775 / 861 | 0% | 0 | 0 / 0 |
muscle | 59% | 308.93 | 473 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0007040 | Biological process | lysosome organization |
GO_0033574 | Biological process | response to testosterone |
GO_0021694 | Biological process | cerebellar Purkinje cell layer formation |
GO_0072676 | Biological process | lymphocyte migration |
GO_1903061 | Biological process | positive regulation of protein lipidation |
GO_1904457 | Biological process | positive regulation of neuronal action potential |
GO_0061518 | Biological process | microglial cell proliferation |
GO_0043627 | Biological process | response to estrogen |
GO_0097066 | Biological process | response to thyroid hormone |
GO_0061436 | Biological process | establishment of skin barrier |
GO_0032715 | Biological process | negative regulation of interleukin-6 production |
GO_0061744 | Biological process | motor behavior |
GO_0008340 | Biological process | determination of adult lifespan |
GO_0031175 | Biological process | neuron projection development |
GO_0032436 | Biological process | positive regulation of proteasomal ubiquitin-dependent protein catabolic process |
GO_0008203 | Biological process | cholesterol metabolic process |
GO_0031333 | Biological process | negative regulation of protein-containing complex assembly |
GO_1905165 | Biological process | regulation of lysosomal protein catabolic process |
GO_1904925 | Biological process | positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization |
GO_0048872 | Biological process | homeostasis of number of cells |
GO_0050905 | Biological process | neuromuscular process |
GO_0009267 | Biological process | cellular response to starvation |
GO_0009268 | Biological process | response to pH |
GO_0023021 | Biological process | termination of signal transduction |
GO_0046513 | Biological process | ceramide biosynthetic process |
GO_0071425 | Biological process | hematopoietic stem cell proliferation |
GO_0033077 | Biological process | T cell differentiation in thymus |
GO_0071548 | Biological process | response to dexamethasone |
GO_0071356 | Biological process | cellular response to tumor necrosis factor |
GO_0051402 | Biological process | neuron apoptotic process |
GO_1905037 | Biological process | autophagosome organization |
GO_0021859 | Biological process | pyramidal neuron differentiation |
GO_0007005 | Biological process | mitochondrion organization |
GO_0050728 | Biological process | negative regulation of inflammatory response |
GO_0019915 | Biological process | lipid storage |
GO_0014004 | Biological process | microglia differentiation |
GO_0043243 | Biological process | positive regulation of protein-containing complex disassembly |
GO_0022904 | Biological process | respiratory electron transport chain |
GO_0046512 | Biological process | sphingosine biosynthetic process |
GO_0048854 | Biological process | brain morphogenesis |
GO_0043407 | Biological process | negative regulation of MAP kinase activity |
GO_0019882 | Biological process | antigen processing and presentation |
GO_0006914 | Biological process | autophagy |
GO_0016241 | Biological process | regulation of macroautophagy |
GO_1901805 | Biological process | beta-glucoside catabolic process |
GO_0030259 | Biological process | lipid glycosylation |
GO_0043524 | Biological process | negative regulation of neuron apoptotic process |
GO_0048469 | Biological process | cell maturation |
GO_0032006 | Biological process | regulation of TOR signaling |
GO_0043161 | Biological process | proteasome-mediated ubiquitin-dependent protein catabolic process |
GO_0035307 | Biological process | positive regulation of protein dephosphorylation |
GO_0006680 | Biological process | glucosylceramide catabolic process |
GO_0005764 | Cellular component | lysosome |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0005802 | Cellular component | trans-Golgi network |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0043202 | Cellular component | lysosomal lumen |
GO_0005765 | Cellular component | lysosomal membrane |
GO_0004336 | Molecular function | galactosylceramidase activity |
GO_0050295 | Molecular function | steryl-beta-glucosidase activity |
GO_0046527 | Molecular function | glucosyltransferase activity |
GO_0005102 | Molecular function | signaling receptor binding |
GO_0005124 | Molecular function | scavenger receptor binding |
GO_0005515 | Molecular function | protein binding |
GO_0004348 | Molecular function | glucosylceramidase activity |
Gene name | GBA1 |
Protein name | Lysosomal acid glucosylceramidase (Lysosomal acid GCase) (EC 3.2.1.45) (Acid beta-glucosidase) (Alglucerase) (Beta-glucocerebrosidase) (Beta-GC) (Beta-glucosylceramidase 1) (Cholesterol glucosyltransferase) (SGTase) (EC 2.4.1.-) (Cholesteryl-beta-glucosidase) (EC 3.2.1.-) (D-glucosyl-N-acylsphingosine glucohydrolase) (Glucosylceramidase beta 1) (Imiglucerase) (Lysosomal cholesterol glycosyltransferase) (Lysosomal galactosylceramidase) (EC 3.2.1.46) (Lysosomal glycosylceramidase) Glucosylceramidase (EC 3.2.1.45) |
Synonyms | GLUC GC GBA |
Description | FUNCTION: Glucosylceramidase that catalyzes, within the lysosomal compartment, the hydrolysis of glucosylceramides/GlcCers (such as beta-D-glucosyl-(1<->1')-N-acylsphing-4-enine) into free ceramides (such as N-acylsphing-4-enine) and glucose . Plays a central role in the degradation of complex lipids and the turnover of cellular membranes . Through the production of ceramides, participates in the PKC-activated salvage pathway of ceramide formation . Catalyzes the glucosylation of cholesterol, through a transglucosylation reaction where glucose is transferred from GlcCer to cholesterol . GlcCer containing mono-unsaturated fatty acids (such as beta-D-glucosyl-N-(9Z-octadecenoyl)-sphing-4-enine) are preferred as glucose donors for cholesterol glucosylation when compared with GlcCer containing same chain length of saturated fatty acids (such as beta-D-glucosyl-N-octadecanoyl-sphing-4-enine) . Under specific conditions, may alternatively catalyze the reverse reaction, transferring glucose from cholesteryl 3-beta-D-glucoside to ceramide (Probable). Can also hydrolyze cholesteryl 3-beta-D-glucoside producing glucose and cholesterol . Catalyzes the hydrolysis of galactosylceramides/GalCers (such as beta-D-galactosyl-(1<->1')-N-acylsphing-4-enine), as well as the transfer of galactose between GalCers and cholesterol in vitro, but with lower activity than with GlcCers . Contrary to GlcCer and GalCer, xylosylceramide/XylCer (such as beta-D-xyosyl-(1<->1')-N-acylsphing-4-enine) is not a good substrate for hydrolysis, however it is a good xylose donor for transxylosylation activity to form cholesteryl 3-beta-D-xyloside . . |
Accessions | ENST00000428024.3 [P04062-4] ENST00000574670.5 ENST00000427500.7 [P04062-5] A0A0G2JLB3 P04062 ENST00000327247.9 [P04062-1] ENST00000613861.4 A0A0G2JNZ5 ENST00000618489.1 A0A068F658 ENST00000572338.5 A0A0G2JNZ0 ENST00000368373.8 [P04062-1] |